SON 是一种重要的RNA剪接因子,在乳腺癌中促进ErbB2和ErbB3的表达
Joshua B Phillips1, Seong-Sik Park2, Cheng-Han Lin3
1Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
British journal of cancer
|September 23, 2024
概括
SON被确定为一种新的RNA剪接因子,对ErbB2/3调节在ErbB2-阳性乳腺癌中至关重要. 针对SON提供了一个有希望的治疗策略来克服耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- ErbB受体在乳腺癌中至关重要,但药物耐药性和调节机制尚不清楚.
- 确定新的治疗点对于改善ErbB阳性乳腺癌治疗结果至关重要.
研究的目的:
- 研究SON (一个拼接因子) 在调节乳腺癌中的ErbB家族基因中的作用.
- 评估SON作为ErbB阳性乳腺癌的潜在治疗标.
主要方法:
- 在公共数据库,患者组织和细胞系中分析SON和ErbB的表达.
- SON的敲除实验评估对细胞增殖,细胞亡,激酶信号传递和RNA剪接的影响.
- 使用异种移植的体内研究来评估治疗潜力.
主要成果:
- 在ErbB2阳性乳腺癌中,SON的表达很高,与生存率差相关.
- SON的淘汰破坏了ErbB2/3RNA剪接,减少了蛋白质的表达,并抑制了下游的信号传输.
- 在体内,SON静音抑制瘤生长,特别是在ErbB2阳性模型中.
结论:
- SON是一种关键的RNA剪接因子,调节乳腺癌中的ErbB2/3表达.
- 对于ErbB2阳性乳腺癌来说,SON是一种新且理想的治疗标.
相关概念视频
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


